NRx Pharmaceuticals, Inc.NRXPNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -0 | -0↓0.0% | -0↓100.0% | -0↓25.0% | -0↓0.0% |
| Operating Income | -22 | -95↓331.5% | -44↑53.4% | -28↑37.8% | -20↑28.6% |
| Net Income | -52 | -93↓79.7% | -40↑57.3% | -30↑24.2% | -25↑16.7% |
| EBITDA | -52 | -93↓79.9% | -40↑57.3% | -30↑24.5% | -24↑19.9% |
| EPS Diluted | -1.51 | -7.44↓392.7% | -0.60↑91.9% | -3.98↓563.3% | -2.39↑39.9% |